En Care 2013, 39(two):82?9. 51. Vlassara H, Uribarri J, Cai W, Goodman S, Pyzik R, Post J, Grosjean F, Woodward M, Striker GE: Effects of sevelamer on HbA1c, inflammation, and sophisticated glycation end products in diabetic kidney illness. Clin J Am Soc Nephrol 2012, 7(six):934?42. 52. Koenig W, Khuseyinova N, Hoffmann MM, M z W, Fr lich M, Hoffmeister A, Brenner H, Rothenbacher D: D14 C(-260) T polymorphism, plasma levels in the soluble endotoxin receptor CD14, their association with chronic infections and risk of steady coronary artery illness. J Am Coll Cardiol 2002, 40(1):34?2. 53. Delmez J, Block G, Robertson J, Chasan-Taber S, Blair A, Dillon M, Bleyer AJ: A randomized, doubleblind, crossover style study of sevelamer hydrochloride and sevelamer carbonate in sufferers on hemodialysis. Clin Nephrol 2007, 68:386?91. 54. Hutchison AJ, Barnett ME, Krause R, Kwan JT, Siami GA, SPD405-309 Lanthanum Study Group: Long-term efficacy and security profile of lanthanum carbonate: outcomes for as much as 6 years of therapy. Nephron Clin Pract 2008, 110(1):c15 23. 55. Slatopolsky E, Liapis H, Finch J: Progressive accumulation of lanthanum inside the liver of regular and uremic rats. Kidney Int 2005, 68(6):2809?813. 56. Lacour B, Lucas A, Auchere D, Ruellan N, Serre Patey NM, Drueke TB: Chronic renal failure is linked with enhanced tissue deposition of lanthanum after 28-day oral administration. Kidney Int 2005, 67(3):1062?069. 57. Yang Z, Schryvers D, Roels F, D’Haese Pc, De Broe ME: Demonstration of lanthanum in liver cells by energy-dispersive X-ray spectroscopy, electron energy loss spectroscopy and high-resolution transmission electron microscopy. J Microsc 2006, 223(Pt two):133?39. 58. Namagondlu G, Key N, Yates L, Mooney J, Sathyamurthy S, Daryanani I, Crowe A, Ledson T, Banerjee A: Lanthanum connected abnormal liver function tests in two individuals on dialysis: a case report. J Med Case Rep 2009, 9(three):9321. 59. Manns B, Stevens L, Miskulin D, Owen WF Jr, Winkelmayer WC, Tonelli M: A systematic critique of sevelamer in ESRD and an evaluation of its possible financial impact in Canada plus the Usa. Kidney Int 2004, 66(three):1239?247. 60. Burke SK, Dillon MA, Hemken DE, Rezabek MS, Balwit JM: Meta-analysis of the impact of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Adv Ren Replace Ther 2003, 10(two):133?45. 61. Brennan A, Akehurst R, Davis S, Sakai H, Abbott V: The cost-effectiveness of lanthanum carbonate inside the remedy of hyperphosphatemia in sufferers with end-stage renal illness. Value Wellness 2007, ten(1):32?1. 62. Brunner-Ziegler S, Fr chl B, Hiebinger C, Zsifkovits J: Effectiveness and cost-efficacy of phosphate binders in hemodialysis.3-Methyl-1H-indazole-5-carboxylic acid site Ann Nutr Metab 2011, 58(4):315?19.1009101-70-5 uses doi:ten.PMID:33640894 1186/1471-2369-14-226 Cite this article as: Zhang et al.: Efficacy and safety of lanthanum carbonate on chronic kidney illness ineral and bone disorder in dialysis patients: a systematic evaluation. BMC Nephrology 2013 14:226.Submit your next manuscript to BioMed Central and take complete benefit of:?Practical on the web submission ?Thorough peer overview ?No space constraints or color figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus and Google Scholar ?Study that is freely obtainable for redistributionSubmit your manuscript at biomedcentral/submit
Research ARTICLEConservation, abundance, glycosylation profile, and localization of the TSP protein family members in Cryptosporidium parvumReceived for publication, December four, 2.
